sPLA2 in EBC During Acute Chest Syndrome
Secretory Phospholipases A2 in Exhaled Breath Condensate From Sickle Cell Patients With Acute Chest Syndrome: A Feasibility Study
Sponsor: Virginia Commonwealth University
A observational or N/A phase clinical study on Acute Chest Syndrome and Sickle Cell Disease, this trial is completed. The trial is conducted by Virginia Commonwealth University and has accumulated 10 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Oct 2018 — Jan 2021 [monthly]
Completed
Status: Recruiting → Completed
-
Aug 2018 — Oct 2018 [monthly]
Recruiting
▶ Show 5 earlier versions
-
Jun 2018 — Aug 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Feb 2018 — Apr 2018 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Oct 2017 — Feb 2018 [monthly]
Not Yet Recruiting NA
-
Sep 2017 — Oct 2017 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Virginia Commonwealth University
For direct contact, visit the study record on ClinicalTrials.gov .